Success of allogeneic marrow transplantation for children with severe aplastic anaemia.
Br. J. Haematol., Jul;158(1):120-8 (2012)
National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-s
Biol. Blood Marrow Transplant., Mar;18(3):334-47 (2012)
NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.
Biol. Blood Marrow Transplant., Dec;17(12):1725-38 (2011)
NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions.
Biol. Blood Marrow Transplant., Oct;17(10):1424-7 (2011)
Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children's Oncology Group study.
Biol. Blood Marrow Transplant., Jan;18(1):84-91 (2012)
Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia.
Blood., Aug;118(5):1421-8 (2011)
A simulation-based comparison of two methods for determining relaxation rates from relaxometry images.
Magn Reson Imaging., May;29(4):497-506 (2011)
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.
Blood., Mar;117(11):3214-9 (2011)
A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantation.
Biol. Blood Marrow Transplant., Sep;17(9):1308-15 (2011)
Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.
J. Clin. Oncol., Jan;29(2):214-22 (2011)
Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children.
Biol. Blood Marrow Transplant., May;17(5):723-8 (2011)
Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation.
Biol. Blood Marrow Transplant., Dec;16(12):1674-81 (2010)
Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.
Biol. Blood Marrow Transplant., Mar;17(3):341-50 (2011)
Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.
J. Clin. Oncol., Feb;28(6):1011-6 (2010)
Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.
Biol. Blood Marrow Transplant., Apr;16(4):515-24 (2010)
Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.
Biol. Blood Marrow Transplant., Feb;16(2):263-72 (2010)
Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.
Biol. Blood Marrow Transplant., Feb;16(2):223-30 (2010)
BK nephropathy in pediatric hematopoietic stem cell transplant recipients.
Pediatr Transplant., Nov;13(7):913-8 (2009)
Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.
Biol. Blood Marrow Transplant., Dec;14(12):1380-4 (2008)
Thyroid function following hematopoietic cell transplantation in children: 30 years' experience.
Blood., Jan;113(2):306-8 (2009)
Late effects following hematopoietic cell transplantation for children.
Biol. Blood Marrow Transplant., Jan;14(1 Suppl 1):88-93 (2008)
HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg/kg of cyclophosphamide.
Biol. Blood Marrow Transplant., Dec;13(12):1455-60 (2007)
Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party.
Blood., Jan;111(2):939-44 (2008)
Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years.
Blood., Feb;111(3):989-96 (2008)
Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease.
Biol. Blood Marrow Transplant., Jun;13(6):683-90 (2007)
Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic d
Blood., Aug;110(4):1379-87 (2007)
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.
Biol. Blood Marrow Transplant., Jan;13(1):1-25 (2007)
Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia.
Blood., Apr;109(7):2791-3 (2007)
Role of allogeneic stem cell transplantation in FLT3/ITD-positive AML.
Blood., Jul;108(1):400; author reply 400-1 (2006)
Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
Br. J. Haematol., Sep;130(5):747-51 (2005)
Pulmonary function in long-term survivors of pediatric hematopoietic cell transplantation.
Pediatr Blood Cancer., Oct;47(5):594-606 (2006)
Survival after recurrence of Ewing's sarcoma family of tumors.
J. Clin. Oncol., Jul;23(19):4354-62 (2005)
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.
Blood., May;105(9):3749-56 (2005)
Final adult height of patients who received hematopoietic cell transplantation in childhood.
Blood., Feb;105(3):1348-54 (2005)
Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia.
Bone Marrow Transplant., Nov;34(9):799-806 (2004)
Duration of immunosuppressive treatment for chronic graft-versus-host disease.
Blood., Dec;104(12):3501-6 (2004)
Diagnosis and clinical management of chronic graft-versus-host disease.
Int. J. Hematol., Apr;79(3):221-8 (2004)
Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma.
JAMA., May;291(19):2335-43 (2004)
Endocrine complications of high-dose therapy with stem cell transplantation.
Pediatr Transplant., Jun;8 Suppl 5:39-50 (2004)
Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Biol. Blood Marrow Transplant., May;10(5):320-7 (2004)
Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
Cancer., Mar;100(6):1268-75 (2004)
Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation.
J. Pediatr. Hematol. Oncol., Feb;26(2):81-90 (2004)
Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience.
Bone Marrow Transplant., Apr;33(8):805-14 (2004)
Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia.
Biol. Blood Marrow Transplant., Nov;9(11):706-13 (2003)
Telomere shortening in hematopoietic stem cell transplantation: a potential mechanism for late graft failure?
Biol. Blood Marrow Transplant., 8(11):597-600 (2002)
Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation.
Int. J. Hematol., Aug;76 Suppl 2:15-28 (2002)
Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome.
Blood., Nov;92(10):3546-56 (1998)
Bone marrow transplantation for pediatric malignancies.
Pediatr. Clin. North Am., Aug;44(4):1005-20 (1997)
Marrow transplant experience for children with severe aplastic anemia.
Am J Pediatr Hematol Oncol., Feb;16(1):43-9 (1994)
Bone marrow transplantation for pediatric leukemia.
Pediatr Ann., Dec;20(12):671-6 (1991)
Long-term effects of bone marrow transplantation.
Pediatrician., 18(1):76-81 (1991)
The use of recombinant human granulocyte macrophage colony-stimulating factor in autologous bone marrow transplantation.
Bone Marrow Transplant., 7 Suppl 3:24-7 (1991)
Late effects in children receiving total body irradiation for bone marrow transplantation.
Radiother Oncol., 18 Suppl 1:82-7 (1990)
Bone marrow transplantation experience for children with aplastic anemia.
Pediatrics., Feb;77(2):179-86 (1986)
Successful treatment of juvenile chronic granulocytic leukemia with marrow transplantation.
Pediatrics., Jan;63(1):44-6 (1979)